Destiny Tech100 has delivered a sharp two-week rally, rising 22% to $29.62, and the most telling signal in the data this week is that short sellers are quietly exiting — not piling in.
The short interest story here is the one worth telling. Estimated shares short have collapsed by roughly 72% over the past month, falling from around 1.6 million shares in early July to just 415,000 now. The direction of travel is unmistakable: shorts have been steadily covering through July and into August, even as the stock ran higher. The week-on-week picture is slightly noisier — shares short ticked up 48% in a single day on August 11 after hitting a recent trough on August 10, suggesting some re-entry at the margin. But the broader trend is one of capitulation, not conviction. Borrowing costs underline this: the cost to borrow has fallen 59% over the past month to just 0.75%, a negligible rate that reflects an uncrowded short book. Availability has actually loosened substantially, running at roughly 354% — meaning more than three shares are available to borrow for every one currently lent out — which removes any structural squeeze pressure. The ORTEX short score of 46.6 is essentially neutral, sitting right at the midpoint of the 0-100 range and barely moving across the past two weeks.
Options traders are not particularly defensive either. The put/call ratio has eased to 0.46, just below its 20-day average of 0.48 and well off the PCR readings above 1.0 that prevailed in early July. That shift is notable: through late June and into the first week of July, the PCR was running above 1.2, pointing to heavy downside hedging. That protective positioning has largely unwound, replaced by a more constructively skewed options market. The z-score is a minimal -0.28, confirming the PCR is sitting comfortably within normal range rather than at any extreme.
The fundamental case for DXYZ remains a premium-to-NAV puzzle. The fund provides retail access to a basket of late-stage private technology companies — the kind of AI-adjacent exposure that has driven appetite — but the discount or premium at which shares trade relative to estimated underlying valuations is the persistent structural debate. No earnings events are scheduled, no analyst coverage appears current, and valuation multiples are unavailable, leaving the market to trade the narrative rather than a hard fundamental anchor. With no institutional flow data to triangulate and insider activity last recorded in July 2025, external catalysts rather than internal signals are driving this week's move.
What to watch next: whether the day-over-day bounce in shares short on August 11 marks the start of renewed short-side interest at the $29-$30 level, or proves to be noise within a broader covering trend, will be the positioning question hanging over the coming week.
See the live data behind this article on ORTEX.
Open DXYZ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
